[Federal Register Volume 65, Number 144 (Wednesday, July 26, 2000)]
[Notices]
[Page 45991]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-18829]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 00N-0930]


Request for Nominations for Working Groups Under the Nonclinical 
Studies Subcommittee of the Advisory Committee for Pharmaceutical 
Science

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for qualified persons to serve on two fact-finding working 
groups being formed to support the Nonclinical Studies Subcommittee of 
the Advisory Committee for Pharmaceutical Science. The working groups 
will identify and report on scientific issues that may benefit from 
focused nonclinical research and collaboration.
    FDA has a special interest in ensuring that women, minority groups, 
and individuals with disabilities are adequately represented on 
advisory committees, and therefore, encourages nominations of qualified 
candidates from these groups. Final selections from among qualified 
candidates for each working group will be based on the expertise 
demonstrated for the specific focus areas and previous experience 
working in these areas.

DATES: All nominations should be received by September 29, 2000.

ADDRESSES: Please submit nominations to Docket No. 00N-0930, Dockets 
Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers 
Lane, rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: David C. Morley, Center for Drug 
Evaluation and Research (HFD-358), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-594-5684, FAX 301-594-2503, e-
mail: [email protected].

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for qualified 
persons to serve on two fact-finding working groups being formed to 
support the Nonclinical Studies Subcommittee of the Advisory Committee 
for Pharmaceutical Science. The working groups will identify and report 
on scientific issues that may benefit from focused nonclinical research 
and collaboration.
    FDA is forming the following two working groups:
     A multidisciplinary working group to identify promising 
areas of nonclinical scientific research to develop biomarkers and/or 
other evolving molecular technologies to identify or predict drug-
induced cardiac tissue injury, and
     A multidisciplinary working group to identify promising 
areas of nonclinical scientific research to develop biomarkers and/or 
other evolving molecular technologies to identify or predict drug-
induced vasculitis.

Criteria

    Persons nominated for the working groups shall have exceptional 
accomplishments and expertise in the scientific fields appropriate to 
the working group. In particular, expertise in genomic and proteomic 
technologies is desired.

Nomination Procedures

    Any interested person or organization may nominate one or more 
qualified persons for one or more of the working groups. Self-
nominations are also accepted. Nominations should include appropriate 
biographical material, a brief (one-half page maximum) endorsement, a 
list of scientific publications relevant to the working group, and a 
statement that the nominee is aware of the nomination and is willing to 
serve on the working group if selected.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: July 18, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-18829 Filed 7-25-00; 8:45 am]
BILLING CODE 4160-01-F